Sharechat Logo

Abano Healthcare completes $35 million capital raising, including shortfall

Monday 28th August 2017

Text too small?

Abano Healthcare said it successfully completed the shortfall bookbuild component of the $35 million capital raise announced on July 26, with strong investor support. 

Last week the Australasian radiology and dental centre operator said 3,878,946 new shares, at a price of $8.15 per share, were taken up by shareholders under its fully underwritten 1 for 5 pro rata renounceable rights offer, representing approximately 92 percent of the new shares available to eligible shareholders under the rights offer.

As a result, it opened a shortfall bookbuild for the remaining 413,563 shares, conducted by Forsyth Barr.

At the time, it said shareholders who did not take up their full entitlements in the rights offer would receive a share of any premium achieved for the rights which they did not take up.

The clearing price under the shortfall bookbuild was $9.25 per share, a premium of $1.10 per share over the application price of $8.15 under the offer. Therefore, eligible shareholders who did not take up their full entitlements will receive $1.10 for each new share not taken up by them. Payment is expected to be made on Sept 1.

The shares taken up under the offer are expected to be allotted and commence trading Aug 30, it said. 

The stock was unchanged at $9.28 and is up 22 percent over the past 12 months. 

(BusinessDesk)



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

NZAS Sign Long Term Contracts
Amended - IFT230 Maturity and Exchange for IFT350
Synlait forecast milk price update
Chorus submits 2023 fibre regulatory report
Infratil Infrastructure Bond Exchange Offer opens
May 31st Morning Report
NZAS and Mercury sign long-term agreement, creating opportunity for future investment in renewables
Meridian and NZAS sign long term contracts
ArborGen Holdings Results for Year Ended 31 March 2024
BAI - Full unaudited results to 31 March 2024